SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " moderna " 35 found 🔀 AI-powered Shuffle
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for intismeran autogene, built from each patient’s tumor and paired with Keytruda, will shrink over time. In August, Merck and Moderna reported that the vaccine delayed recurrence and spread in a 1,137-patient Phase 3 melanoma trial, […]
Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know
A number of stocks jumped in the morning session after Morningstar reported that challenging macroeconomic conditions across broader equity markets drove a rotation into healthcare, lifting the sector index by approximately 7% quarter-to-date to reach a 5% valuation premium.
Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the morning session after Morningstar reported that challenging macroeconomic conditions across broader equity ma...
Health Care Roundup: Market Talk
Find insight on Moderna, Novonesis, Merck KGaA and more in the latest Market Talks covering the health care sector.
Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.
FDA approves 1st flu shot using same technology as COVID vaccines
Previously, the COVID-19 immunizations made by Pfizer and Moderna were the only mRNA vaccines on the market.
FDA Approves the First mRNA Flu Vaccine
The shot, made by Moderna, will be available for this year's upcoming flu season.
Covid can reactivate dormant viruses, according to study
A CDC director officially confirmed, Moderna's mRNA flu shot approved, and other health news from Morning Rounds
FDA approves first mRNA-based flu vaccine
The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
A new type of flu shot is coming after FDA approves mRNA-based vaccine
The agency’s former top vaccine regulator declined to review the Moderna shot, and it’s now likely to face pushback from allies of the health secretary.
FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.
Anthropic’s life science plans; Novartis CEO on China deals; and more
Welcome back to Endpoints Weekly! We’re gearing up for a busy week of earnings coverage, as Moderna, AstraZeneca, GSK, Bristol Myers Squibb and more are set to report their Q2 ...
Moderna highlights expanding mRNA platform at Science Day
Moderna's Horizon programme contains a variety of mRNA assets in varying stages of development, including a preclinical in vivo candidate.
Moderna Science Day Highlights Expanding Potential of mRNA Platform
Provides broad overview of Company's research and early development programs expected to continue to fuel future growth Highlights validation of T-cell engager modality with mRNA-2808 in multiple myeloma, supporting rapid advancement of second T-cell ...
Flagship Pioneering and Lean Business Services Company Announce Collaboration to Advance Healthcare Innovation and AI-Enabled Biomedical Research in Saudi Arabia
/PRNewswire/ -- Flagship Pioneering, the scientific innovation company behind Moderna, Generate Biomedicines, and more than 100 other life sciences ventures,...
Covid vaccine study the acting CDC director blocked is published in an outside journal
The findings suggest that Covid vaccines reduced the likelihood of severe illness last fall and winter.
FDA panel considers first-of-its-kind flu vaccine using mRNA technology
The FDA advisory panel is meeting Thursday to consider it
FDA panel considers first-of-its-kind flu vaccine using mRNA technology
The FDA advisory panel is meeting Thursday to consider it
Moderna partners with global health coalition to develop Bundibugyo Ebola vaccine
Moderna said on Monday it has partnered with the Coalition for Epidemic Preparedness Innovations to develop a potential vaccine against Bundibugyo ebolavirus, the strain linked to the ongoing Ebola outbreak in eastern Democratic Republic of Congo.
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100% tariffs on imports of branded and patented drugs.
European health agency recommends approving Moderna’s combined flu, COVID vaccine
The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be granted market authorization in the European Union, marking the fir…
Moderna got a win from the FDA, but political headwinds remain a concern for vaccine makers
The firestorm has highlighted the perilous environment that Moderna and other vaccine makers find themselves
Health Care Roundup: Market Talk
Find insight on Novo Nordisk, Moderna, EssilorLuxottica and more in the latest Market Talks covering Health Care.
US FDA declines Moderna flu vaccine review amid vaccine guidance rollback
CEO Stephane Bancel said the letter refusing review did not cite 'any safety or efficacy concerns'.
U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine
The F.D.A.’s refusal to examine the company’s mRNA shot drew widespread criticism from doctors and was divisive within the agency.
FDA won’t review Moderna application for first mRNA-based flu vaccine
The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to federal vaccine approvals.
FDA declines to review Moderna's mRNA flu shot
Under Health Secretary Robert F. Kennedy Jr., the Food and Drug Administration has taken an aggressive stance against mRNA technology.
Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
As the Trump administration erodes U.S. | As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans to pull away from late-stage clinical trial investments in the area.
Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25
Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 Earnings Call Improves 2025 expected GAAP operating expenses by $200 million since 3Q25 Earnings Call Increases 2025 projected year-end ...
Moderna chair warns of ‘dystopia’ amid US science pullback
“Corrosive doubt” has led to the return of measles in the US and elsewhere, Noubar Afeyan said.
‘An undoing of the scientific method’: Flagship CEO warns of government threats to US biotech industry
The Trump administration spent 2025 taking a sledgehammer to science, obliteratin | The Trump administration spent 2025 taking a sledgehammer to science, obliterating funding and reshaping agencies like the FDA and National Institutes of Health through layoffs and restrictive new policies. In a new letter, Noubar Afeyan, Ph.D., co-founder of Moderna and CEO of Flagship Pioneering, warns that these actions risk undermining the foundations of science itself to the ultimate detriment of health and biotech innovation in America.
Investor behind Moderna says U.S. policy is ‘taking a sledgehammer to our miracle machine’
Noubar Afeyan, one of biotech’s top investors, says U.S. policy is "taking a sledgehammer to our miracle machine."
Moderna Founder Warns US Doubts on Science Threaten Biotech Edge
The US risks falling behind in biotechnology as the government cuts funding and skepticism over vaccines grows, according to Moderna Inc.’s co-founder and Chairman Noubar Afeyan.
FDA chief says Biden administration withheld data on heart risk from Covid vaccines
Myocarditis is a known — but small — side effect of the mRNA Covid vaccines from Pfizer and Moderna, information that federal agencies have discussed openly since 2021.